U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT06808672) titled 'Biomarkers of Cancer-associated Miositis' on March 22, 2024.
Brief Summary: The project is about dermatomyositis (DM), an autoimmune disease characterized by inflammation in the skeletal muscles and skin. Patients with DM have an increased risk of cancer, with a cancer incidence between 5.5% and 42%. Cancers in these patients are one of the leading causes of death. Some myositis-specific autoantibodies have been discovered and some of them are associated with cancer development. However, DM patients negative for all the known autoantibodies can also develop cancer. The Investigator hypothesized that antibodies against plasma membrane...